![Bob Disbrow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bob Disbrow
No open positions remaining
Net worth: 31 M $ as of 29/09/2026
Finance
Profile
Mr. Disbrow joined Haywood in 1999 from First Marathon Securities where he was a director and Branch Manager of the Vancouver office.
A co-founder of First Marathon, he managed the firm's risk capital fund for 10 years and its equity fund for five years.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Eupraxia Pharmaceuticals, Inc.
 Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs 5.11% | 29/09/2025 | 3,368,150 ( 5.11% ) | 31 M $ | 29/09/2026 |
Former positions of Bob Disbrow
| Companies | Position | End |
|---|---|---|
Haywood Securities, Inc.
 Haywood Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Institutional Sales | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Haywood Securities, Inc.
Haywood Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
- Stock Market
- Insiders
- Bob Disbrow
